281 related articles for article (PubMed ID: 24322333)
1. Maraba virus as a potent oncolytic vaccine vector.
Pol JG; Zhang L; Bridle BW; Stephenson KB; Rességuier J; Hanson S; Chen L; Kazdhan N; Bramson JL; Stojdl DF; Wan Y; Lichty BD
Mol Ther; 2014 Feb; 22(2):420-429. PubMed ID: 24322333
[TBL] [Abstract][Full Text] [Related]
2. Considerations for Clinical Translation of MG1 Maraba Virus.
Breitbach CJ
Methods Mol Biol; 2020; 2058():285-293. PubMed ID: 31486046
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.
McGray AJR; Huang RY; Battaglia S; Eppolito C; Miliotto A; Stephenson KB; Lugade AA; Webster G; Lichty BD; Seshadri M; Kozbor D; Odunsi K
J Immunother Cancer; 2019 Jul; 7(1):189. PubMed ID: 31315674
[TBL] [Abstract][Full Text] [Related]
4. Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice.
Aitken AS; Roy DG; Martin NT; Sad S; Bell JC; Bourgeois-Daigneault MC
J Immunother; 2018 Apr; 41(3):125-129. PubMed ID: 29293165
[TBL] [Abstract][Full Text] [Related]
5. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.
Bridle BW; Boudreau JE; Lichty BD; Brunellière J; Stephenson K; Koshy S; Bramson JL; Wan Y
Mol Ther; 2009 Oct; 17(10):1814-21. PubMed ID: 19603003
[TBL] [Abstract][Full Text] [Related]
6. Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.
Atherton MJ; Stephenson KB; Nikota JK; Hu QN; Nguyen A; Wan Y; Lichty BD
Vaccine; 2018 Apr; 36(16):2181-2192. PubMed ID: 29544689
[TBL] [Abstract][Full Text] [Related]
7. Development and applications of oncolytic Maraba virus vaccines.
Pol JG; Atherton MJ; Bridle BW; Stephenson KB; Le Boeuf F; Hummel JL; Martin CG; Pomoransky J; Breitbach CJ; Diallo JS; Stojdl DF; Bell JC; Wan Y; Lichty BD
Oncolytic Virother; 2018; 7():117-128. PubMed ID: 30538968
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.
Workenhe ST; Simmons G; Pol JG; Lichty BD; Halford WP; Mossman KL
Mol Ther; 2014 Jan; 22(1):123-31. PubMed ID: 24343053
[TBL] [Abstract][Full Text] [Related]
9. Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.
Brun J; McManus D; Lefebvre C; Hu K; Falls T; Atkins H; Bell JC; McCart JA; Mahoney D; Stojdl DF
Mol Ther; 2010 Aug; 18(8):1440-9. PubMed ID: 20551913
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
Tzelepis F; Birdi HK; Jirovec A; Boscardin S; Tanese de Souza C; Hooshyar M; Chen A; Sutherland K; Parks RJ; Werier J; Diallo JS
Mol Ther Oncolytics; 2020 Dec; 19():240-252. PubMed ID: 33209979
[TBL] [Abstract][Full Text] [Related]
11. Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats.
Hummel J; Bienzle D; Morrison A; Cieplak M; Stephenson K; DeLay J; Woods JP; Lichty BD; Bridle BW
Sci Rep; 2017 Nov; 7(1):15738. PubMed ID: 29146945
[TBL] [Abstract][Full Text] [Related]
12. Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.
Lemay CG; Rintoul JL; Kus A; Paterson JM; Garcia V; Falls TJ; Ferreira L; Bridle BW; Conrad DP; Tang VA; Diallo JS; Arulanandam R; Le Boeuf F; Garson K; Vanderhyden BC; Stojdl DF; Lichty BD; Atkins HL; Parato KA; Bell JC; Auer RC
Mol Ther; 2012 Sep; 20(9):1791-9. PubMed ID: 22760544
[TBL] [Abstract][Full Text] [Related]
13. IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity.
Yang M; Giehl E; Feng C; Feist M; Chen H; Dai E; Liu Z; Ma C; Ravindranathan R; Bartlett DL; Lu B; Guo ZS
Cancer Immunol Immunother; 2021 Sep; 70(9):2467-2481. PubMed ID: 33538860
[TBL] [Abstract][Full Text] [Related]
14. Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.
Lapteva N; Aldrich M; Weksberg D; Rollins L; Goltsova T; Chen SY; Huang XF
J Immunother; 2009; 32(2):145-56. PubMed ID: 19238013
[TBL] [Abstract][Full Text] [Related]
15. Customized Viral Immunotherapy for HPV-Associated Cancer.
Atherton MJ; Stephenson KB; Pol J; Wang F; Lefebvre C; Stojdl DF; Nikota JK; Dvorkin-Gheva A; Nguyen A; Chen L; Johnson-Obaseki S; Villeneuve PJ; Diallo JS; Dimitroulakos J; Wan Y; Lichty BD
Cancer Immunol Res; 2017 Oct; 5(10):847-859. PubMed ID: 28912369
[TBL] [Abstract][Full Text] [Related]
16. Rhabdoviruses as vaccine platforms for infectious disease and cancer.
Zemp F; Rajwani J; Mahoney DJ
Biotechnol Genet Eng Rev; 2018 Apr; 34(1):122-138. PubMed ID: 29781359
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning.
Pol JG; Atherton MJ; Stephenson KB; Bridle BW; Workenhe ST; Kazdhan N; McGray AR; Wan Y; Kroemer G; Lichty BD
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32792361
[TBL] [Abstract][Full Text] [Related]
18. A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.
Das K; Belnoue E; Rossi M; Hofer T; Danklmaier S; Nolden T; Schreiber LM; Angerer K; Kimpel J; Hoegler S; Spiesschaert B; Kenner L; von Laer D; Elbers K; Derouazi M; Wollmann G
Nat Commun; 2021 Aug; 12(1):5195. PubMed ID: 34465781
[TBL] [Abstract][Full Text] [Related]
19. Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy.
Ricca JM; Oseledchyk A; Walther T; Liu C; Mangarin L; Merghoub T; Wolchok JD; Zamarin D
Mol Ther; 2018 Apr; 26(4):1008-1019. PubMed ID: 29478729
[TBL] [Abstract][Full Text] [Related]
20. Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors.
Speck T; Heidbuechel JPW; Veinalde R; Jaeger D; von Kalle C; Ball CR; Ungerechts G; Engeland CE
Clin Cancer Res; 2018 May; 24(9):2128-2137. PubMed ID: 29437789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
